Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Seeks To Write MedGuides Outside REMS Process

Jun 21 2010

• By The Pink Sheet

Related Content

REMS Assessments Need Very Recent Data, FDA Draft Guidance Says

Oct 05 2009

U.S. Department of Labor Supports Novartis Sales Reps In Their Overtime Suit

Oct 15 2009

GlaxoSmithKline in a Rare-Disease Pact with Prosensa for RNA-modulation Drugs

Oct 13 2009

FTC's Health Care Reform Plan: Save $12 Billion With Reverse Settlement Ban

Jun 29 2009

Defining Innovation: UK's NICE Responds To Recent Criticism Over Its Methods

Sep 15 2009

CMS Defends Oral ESRD Drug Inclusion In Proposed Bundling Rule

Sep 21 2009

Novartis Gleevec For Leukemia Will Be In Pharmacies By Mid-May

May 14 2001

Pfizer Thinks Small: Partnership With Protalix On Gaucher Drug Eyes Cheaper Plant-Based Production

Dec 07 2009

Sanofi-Aventis Will Enter U.S. OTC Market By Paying $1.9 Billion For Chattem

Dec 21 2009

Medicare ESA Coverage Will Not Experiment With Clinical Trial Approach

Aug 06 2007

Plan B Lightning May Strike Again: Compliance May Not End Political Storm

Apr 27 2009

Mead Johnson Likely To Draw Suitors Following BMS Split

Nov 23 2009

Conflicts of Interest By Academics Should Be Better Policed By NIH, OIG Says

Nov 23 2009

Erectile Dysfunction Class Labeling Does Not Assert Causal Link To Vision Loss

Jul 08 2005

Viagra’s Second Wind: Pfizer Revatio Approved For Pulmonary Hypertension

Jun 13 2005

GLP-1 Showdown Set For Fall: Bydureon Gets New October Review Deadline

May 06 2010

Icahn Tries To Rain On Genzyme's Investor Day Parade With Proxy Seeking Termeer's Ouster

May 06 2010

WellPoint's Comparative Effectiveness Research Guidelines Describe How It Will Determine Usefulness Of Studies

May 20 2010

Access To ESRD Drugs Under Bundled Medicare Payments Concerns GAO

May 10 2010

Patent Reform Bill Is Bogged Down, Rep. Conyers Reports At Hearing

May 10 2010

FDA Aims For Flexibility In Upcoming Drug/Companion Diagnostic Guidance

May 10 2010

Provenge Poised For Broad Insurance Coverage, Despite Grumbles On Price

May 24 2010

Final Health Reform Bill Looks Positive For Pharma Firms

Mar 22 2010

REMS Must Be Designed With Input From Doctors, Kaiser Tells FDA In Petition

Jan 18 2010

Regulatory Science: FDA Gets Help From NIH, But Is It Enough?

Mar 01 2010

With Isentress Sales Booming, New Integrase Inhibitors Step Up To The Plate

Mar 01 2010

Gleevec's Rapid Rise To Blockbuster Status

Mar 01 2010

Amgen's Prolia Gains First Regulatory Win: Market Approval in Europe

May 28 2010

FDA Cites Long-Term Precedent In Blocking Retail Genetic Screening Plans

May 17 2010

MedCAC Review Of ESAs In Renal Disease To Help Determine Need For NCD

Mar 29 2010

Will Cabazitaxel Success Derail Other Prostate Cancer Trials?

Mar 15 2010

With One Foot Firmly Planted In Oncology, Roche Moves The Other Into CV/Metabolic

Mar 18 2010

Orphaned No Longer: Big Pharma Embraces Drugs for Niche Markets

Feb 01 2010

Valeant Pharmaceuticals To Buy Aton For $318 Mil.; Bolsters U.S. Specialty Business

May 03 2010

Commissioner Margaret Hamburg: Moving FDA Beyond A Regulatory Agency

Jul 06 2009

NIH Director Nominee Collins May Push Translational Medicine Into Spotlight

Jul 13 2009

Amgen, GSK To Team Up On Denosumab Commercialization in Europe

Jul 27 2009

Interagency Communication On Trial Designs Urged At FDA/NIH Stakeholder Meeting

Jun 07 2010

Walgreens Pulls 7,500 Pharmacies Out Of Play For Future Network Contracts With CVS Caremark

Jun 07 2010

European Pricing Discontent: A Summer Of Freezes, Cutbacks And Austerity

Jun 07 2010

Supreme Court Limits On Whistleblower Suits Trumped By Health Care Reform

Apr 05 2010

Earlier Attention To REMS Could Keep Drug Approvals On Schedule, Industry Says At FDA Meeting

Apr 12 2010

Prolia Pricing: A High Bar For Osteoporosis But Room To Tap Oncology Potential

Jun 03 2010

Emergency Contraceptive Ella Needs Minimal Risk Management, Panel Says

Jun 21 2010

NIH's Revised Conflict Of Interest Policy Will Close The Nemeroff Loophole, Collins Tells Congress

Jun 21 2010

Post-Marketing Study Of Emergency Contraceptive Ella Would Be Challenging

Jun 21 2010

CVS Caremark Says Dropping Walgreens Will Have Minimal Effect On Pharmacy Access

Jun 09 2010

Novo Nordisk Faced Tough Decision in Greece: Cut Prices And Make A Loss Or Oppose Government Plans

Jun 02 2010

Valeant's Investor Day Leaves Wall Street Recommending A "Buy" On Shares

Jun 18 2010

Biomarker Qualification Should Be Multi-Step Process, Regulators Say

Jun 14 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window